Molina Healthcare, Inc. recently released its second-quarter earnings for 2024. Analysts have positively remarked on the earnings that beat expectations due to the company's strong medicaid growth. Molina reported GAAP EPS of $5.17 and reaffirmed its FY24 EPS view of 'at least' $23.50, beating the consensus of $23.34. Recently, Molina announced the purchase of ConnectiCare as EmblemHealth focuses on NYC. This acquisition has put the spotlight on Molina Healthcare's stock. However, the future view of Molina Healthcare (NYSE:MOH) is recommended as a 'hold' or 'fold'. Despite this, the company showed strong earnings growth in Q4 and the full year 2023. They have also exceeded expectations amid revenue surge for Q1 2024. Molina Healthcare was awarded new Medicaid contracts in Florida with potential expansion in New Region 5. However, there was a dip in Molina's stock after the analyst downgrade. Despite the low point, Molina Healthcare's stock is expected to rise following strong future growth strategies. Molina Healthcare has seen consistent growth with shareholders earning a 16% CAGR over the last five years.
Molina Healthcare MOH News Analytics from Sat, 28 Oct 2023 07:00:00 GMT to Sun, 28 Jul 2024 22:55:53 GMT -
Rating 5
- Innovation 3
- Information 7
- Rumor -2
